Notice!
On November 30th 2022 the FDA removed the emergency use authorization for the monoclonal antibody, Bebtelovimab. As such, we are no longer providing home infusions of monoclonal antibodies for the treatment of Covid 19. Please contact your primary care physician for other treatment options.
  • Skip to primary navigation
  • Skip to main content
  • Skip to footer

American Infusion Services

  • Home Treatment
  • LTC Facilities
  • Evusheld
  • Jobs
  • Resources
  • Contact
  • Book Appointment
  • Home Treatment
  • LTC Facilities
  • Evusheld
  • Jobs
  • Resources
  • Contact
  • FAQs
  • Book Appointment
Smiling nurse

Monoclonal Antibody Therapy (mAb) for COVID-19

Check if you’re eligible for at-home mAbs


Monoclonal antibody treatment can reduce the risk of severe illness and hospitalization when you test positive for COVID-19. American Infusion’s skilled team offers mAb therapy in the convenience of your home or LTC facility.

locator

Currently servicing parts of:
New York, New Jersey, Pennsylvania, Maryland and Ohio

Find out more about mAbs for your facility

Contact Us

Emergency use

FDA-authorized

Monoclonal antibody therapy is for emergency use in individuals with high-risk COVID factors or in danger of developing severe illness.

Home Treatment

Convenient At-Home Treatment

We offer monoclonal antibody therapy and treatment systems direct to your home or long-term care facility, administered by American Infusion trained nursing staff.

logo

How can we help you combat COVID-19?

nurse-icon

mAbs for At-Home Treatment

Protect yourself and your loved ones from severe illness and hospitalizations due to COVID-19. If you tested positive for COVID, you may be eligible for safe and effective mAb treatment in the convenience of your home.

Get Home Treatment

hospital icon

mAbs for Long-Term Care Facilities

Protect your residents from severe illness and hospitalization with mAb therapy. A resident who tests positive for COVID-19 is likely eligible for mAbs therapy treatment.

Get Treatment for Your LTC Facility

nurse posing with seniors

mAbs are administered directly after exposure to COVID-19 when you test positive, or up to 7 days after onset of symptoms.

70%-85% Reduction In Hospitalizations

Monoclonal antibody therapy reduces the chance of severe illness, hospitalization and patient fatalities.

80% Reduction In Spread

mAbs treatment reduces the spread of COVID-19 and infection among patients’ households.

We’re Hiring!

Nurses Apply Here
logo-without-type

Protect your family. Protect your residents.

Check if you’re eligible for at-home mAbs

Find out more about mAbs for your facility

Contact Us

Footer

carroll-county-logo
© Copyright American Infusion.
All rights reserved.

Contact Us

info@americaninfusion.com

1-855-264-6387

Quick Links

  • Home Treatment
  • LTC Facilities
  • Jobs
  • Resources
  • FAQs
  • Contact